about
Imported Zika virus infection from the Cook Islands into Australia, 2014Highly divergent dengue virus type 1 genotype sets a new distance recordAssessment of Local Mosquito Species Incriminates Aedes aegypti as the Potential Vector of Zika Virus in AustraliaDevelopment of immunoglobulin M capture enzyme-linked immunosorbent assay to differentiate human flavivirus infections occurring in Australia.Bartonella rattaustraliani sp. nov., Bartonella queenslandensis sp. nov. and Bartonella coopersplainsensis sp. nov., identified in Australian rats.Scrub typhus in north Queensland.Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008.Hendra virus infection in a veterinarian.The Chikungunya Virus Capsid Protein Contains Linear B Cell Epitopes in the N- and C-Terminal Regions that are Dependent on an Intact C-Terminus for Antibody RecognitionNo evidence of prolonged Hendra virus shedding by 2 patients, AustraliaImplications of dengue outbreaks for blood supply, Australia.Dengue in north Queensland, 2005-2008.Viraemic importations of dengue into north Queensland, 2009.Multiple outbreaks of dengue serotype 2 in north Queensland, 2003/04.An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait.First report of Zika virus infection in a returned traveller from the Solomon Islands.Bartonella australis sp. nov. from kangaroos, Australia.The appearance of a second genotype of Japanese encephalitis virus in the Australasian region.Heterogeneity of susceptibility to fluoroquinolones in Bartonella isolates from Australia reveals a natural mutation in gyrA.Detection of Specific ZIKV IgM in Travelers Using a Multiplexed Flavivirus Microsphere Immunoassay.On the Home Front: Specialized Reference Testing for Dengue in the Australasian RegionJapanese encephalitis acquired near Port Moresby: implications for residents and travellers to Papua New GuineaErratum: Pyke, A.T. et al. On the Home Front: Specialized Reference Testing for Dengue in the Australasian Region. Trop. Med. Infect. Dis. 2018, 3, 75
P50
Q22330742-B61BC35D-D414-4FC9-8194-27A827D17B2BQ24289288-A707C19B-349B-47C8-86C2-19350135F34BQ27468680-730A98A1-788F-4792-BF3C-74D4EEBB9301Q27469433-0B956E15-390B-4430-B607-04BC103FF1E8Q33486323-04DDBB18-5EB0-400C-9E79-D8E8C7960D44Q33635557-C2199962-FCEA-42E1-B58C-C5D18D0A37B1Q34216124-6AEF6A4E-B0D5-4551-BAC0-C30EF9923CD0Q34583061-4ACCFE02-9D6F-4FDF-9605-E18F6993C143Q35808656-20471DEC-9FA2-4DDD-B444-7727F2148DFEQ36570479-754238E5-B08A-45D2-B8B6-057EEC48E391Q36825504-122EAFB0-C1C5-4E05-AC62-DF0EB4DBAA38Q37624661-EFB87F05-71A3-4915-8EF2-2280DB88982DQ39044682-25D6177F-6DCA-43EA-B3DD-88F56886A0CCQ39044708-A517B1D4-BE0D-4845-94D1-925C7BCA58C3Q39044715-A20FD3E9-ADA9-4ED3-A768-F9638469C2BFQ40060673-AE9534CD-417F-4798-8658-B281B8933155Q42769294-3038D941-C871-4828-9DD7-ADF744EE2E9DQ43036051-086A944B-66B7-4E5B-82BE-0D87D635543AQ46457739-483FFBAE-CEC8-4597-8FA9-E6466F9843D9Q55084478-E7940A54-D965-488F-96C8-6FB2A13DBC66Q56762404-05619C7A-CB2B-40BB-B426-BCF26D853022Q56762517-40B25231-1AF2-4456-BE87-D9A97FE727BDQ90775588-B47356E1-2609-446F-AF52-E4BCD93ED09B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carmel T Taylor
@ast
Carmel T Taylor
@en
Carmel T Taylor
@es
Carmel T Taylor
@nl
Carmel T Taylor
@sl
type
label
Carmel T Taylor
@ast
Carmel T Taylor
@en
Carmel T Taylor
@es
Carmel T Taylor
@nl
Carmel T Taylor
@sl
prefLabel
Carmel T Taylor
@ast
Carmel T Taylor
@en
Carmel T Taylor
@es
Carmel T Taylor
@nl
Carmel T Taylor
@sl
P106
P31
P496
0000-0001-6283-2695